Shape changes induced by N-terminal platination of ubiquitin by cisplatin

Journal of the American Society for Mass Spectrometry

Volumn 21, Issue 7, 2010, Pages 1097-1106

  Williams, Jonathan P ^a   Phillips, Hazel I A ^a   Campuzano, Iain ^b   Sadler, Peter J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b WATERS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER DRUG; BIOLOGICAL ACTIVITIES; CHARGE STATE; CHROMATOGRAPHIC SEPARATIONS; CIS-PLATIN; CONFORMATIONAL CHANGE; DENATURING CONDITIONS; GASPHASE; IN-VIVO; ION MOBILITY; ION MOBILITY-MASS SPECTROMETRY; LOW-ENERGY COLLISION-INDUCED DISSOCIATION; N-TERMINALS; PLATINATION; PROTEIN INTERACTION; SHAPE CHANGE; TANDEM MS; TRAVELING WAVE; UBIQUITIN;

BINDING ENERGY; CONFORMATIONS; IONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLATINUM; PLATINUM COMPOUNDS;

PROTEINS;

CISPLATIN; METHIONINE; TRYPSIN; UBIQUITIN;

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ION MOBILITY SPECTROMETRY; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN MODIFICATION; TANDEM MASS SPECTROMETRY;

ANIMALS; CATTLE; CISPLATIN; ERYTHROCYTES; IONS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TRYPSIN; UBIQUITIN;

EID: 77953961361     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2010.02.012     Document Type: Article

References (47)

1. Jamieson E.R., Lippard S.J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem. Rev. 1999, 99:2467-2498.
2. Eastman A. The Mechanism of Action of Cisplatin: From Adducts to Apoptosis. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug 1999, 111. VCHA and Wiley-VCH, Zurich. B. Lippert (Ed.).
3. Barry M.A., Behnke C.A., Eastman A. Activation of Programmed Cell Death (apoptosis) by Cisplatin, Other Anticancer Drugs, Toxins, and Hyperthermia. Biochem. Pharmacol. 1990, 40:2353-2362.
4. DeConti R.C., Toftness B.R., Lange R.C., Creasey W.A. Clinical and Pharmacological Studies with cis-Diamminedichloroplatinum(II). Cancer Res. 1973, 33:1310-1315.
5. Litterst C.L., Schweiter V.G. Increased Tissue Deposition and Decreased Excretion of Platinum Following Administration of Cisplatin to Cisplatin-Pretreated Animals. Cancer Chemother. Pharmacol. 1984, 12:46-49.
6. Lokich J., Anderson N. Carboplatin Versus Cisplatin in Solid Tumors: An Analysis of the Literature. Ann. Oncol. 1998, 9:13-21.
7. Gidden J., Bowers M.T. Gas-Phase Conformations of Deprotonated and Protonated Mononucleotides Determined by Ion Mobility and Theoretical Modeling. J. Phys. Chem. B 2003, 107:12829-12837.
8. n Oligonucleotides in a Solvent-Free Environment. J. Am. Chem. Soc. 2004, 126:15132-15140.
9. Baker E.S., Gidden J., Ferzoco A., Bowers M.T. Sodium Stabilization of Dinucleotide Multiplexes in the Gas Phase. Phys. Chem., Chem. Phys. 2004, 6:2786-2795.
10. Gidden J., Baker E., Ferzoco A., Bowers M.T. Structural Motifs of DNA Complexes in the Gas Phase. Int. J. Mass Spectrom. 2005, 240:183-193.
11. Koeniger S.L., Clemmer D.E. Resolution and Structural Transitions of Elongated States of Ubiquitin. J. Am. Soc. Mass Spectrom. 2007, 18:322-331.
12. Valentine S.J., Counterman A.E., Clemmer D.E. Conformer-Dependent Proton-Transfer Reactions of Ubiquitin Ions. J. Am. Soc. Mass Spectrom. 1997, 8:954-961.
13. Wright P.J., Zhang J., Douglas D.J. Conformations of Gas-Phase Ions of Ubiquitin, Cytochrome c, Apomyoglobin, and β-Lactoglobulin Produced from Two Different Solution Conformations. J. Am. Soc. Mass Spectrom. 2008, 19:1913.
14. Myung S., Badman E.R., Lee Y.J., Clemmer D.E. Structural Transitions of Electrosprayed Ubiquitin Ions Stored in an Ion Trap over ~10 ms to 30 s. J. Phys. Chem. A 2002, 106:9976-9982.
15. Hoeller D., Hecker C.M., Dikic I. Ubiquitin and Ubiquitin-Like Proteins in Cancer Pathogenesis. Nat. Rev. Cancer 2006, 6:776-788.
16. Isoe T., Haito M., Shirai A., Tsuruo T. Inhibition of Different Steps of the Ubiquitin System by Cisplatin and Aclarubicin. BBA-Gen. Subjects 1992, 1117:131-135.
17. Isoe T., Haito M., Hirai R., Tsuruo T. Inhibition of Ubiquitin-ATP-dependent Proteolysis and Ubiquitination by Cisplatin. Anticancer Res. 1991, 11:1905-1909.
18. Casini A., Gabbiani C., Mastrobuoni G., Messori L., Moneti G., Pieraccini G. Exploring Metallodrug-Protein Interactions by ESI Mass Spectrometry: The Reaction of Anticancer Platinum Drugs with Horse Heart Cytochrome. c. Chem. Med. Chem. 2006, 1:413-417.
19. Karotki A.V., Vašák M. Reaction of Metallothionein-3 with Cisplatin and Transplatin. J. Biol. Inorg. Chem. 2009, 14:1129-1138.
20. Gullo J., Litterst C.L., Maguire P.J., Sikis B.J., Holth D.F., Woodley P.V. Pharmacokinetics and Protein Binding of cis-Dichlorodiamine Platinum(II) Administered as a 1-hour or as a 20-hour infusion. Cancer Chemother. Pharmacol. 1980, 5:21-26.
21. Lázníčková A., Lázníček M., Květina J., Drobník J. Pharmacokinetics and Plasma Protein Binding of Two Platinum Cytostatics CHIP and CBDCA in Rats. Cancer Chemother. Pharmacol. 1986, 17:133-136.
22. Ivanov A.I., Christodoulou J., Parkinson J.A., Barnham K.J., Tucker A., Woodrow J., Sadler P.J. Cisplatin Binding Sites on Human Albumin. J. Biol. Chem. 1998, 273:14721-14730.
23. Gibson D., Costello C.E. A Mass Spectral Study of the Binding of the Anticancer Drug Cisplatin to Ubiquitin. Eur. Mass Spectrom. 1999, 5:501-510.
24. Peleg-Shulman T., Najajreh Y., Gibson D. Interactions of Cisplatin and Transplatin with Proteins. Comparison of Binding Kinetics, Binding Sites, and Reactivity of the Pt-Protein Adducts of Cisplatin and Transplatin Towards Biological Nucleophiles. J. Inorg. Biochem. 2002, 91:306-311.
25. Hartinger C.G., Ang W.H., Casini A., Messori L., Keppler B.K., Dyson P.J. Mass Spectrometric Analysis of Ubiquitin-Platinum Interactions of Leading Anticancer Drugs: MALDI versus ESI. J. Anal. At. Spectrom. 2007, 22:960-967.
26. Hartinger C.G., Tsybin Y.O., Fuchser J., Dyson P.J. Characterization of Platinum Anticancer Drug Protein-Binding Sites Using a Top-Down Mass Spectrometric Approach. Inorg. Chem. 2008, 47:17-19.
27. Wild B.J., Green B.N., Cooper E.K., Lalloz M.R.A., Erten S., Stephens A.D., Layton D.M. Rapid Identification of Hemoglobin Variants by Electrospray Ionization Mass Spectrometry. Blood Cell. Mol. Dis. 2001, 27:691-704.
28. 2. Ind. J. Chem. 1970, 8:193-194.
29. Pringle S.D., Giles K., Wildgoose J.L., Williams J.P., Slade S.E., Thalassinos K., Bateman R.H., Bowers M.T., Scrivens J.H. An Investigation of the Mobility Separation of Some Peptide and Protein Ions Using a New Hybrid Quadrupole/Traveling Wave IMS/oa-TOF Instrument. Int. J. Mass Spectrom. 2007, 261:1-12.
30. Ruotolo B.T., Giles K., Campuzano I., Sandercock A.M., Bateman R.H., Robinson C.V. Evidence for Macromolecular Protein Rings in the Absence of Bulk Water. Science 2005, 310:1658-1661.
31. Wildgoose J.L., Giles K., Pringle S.D., Koeniger S.L., Valentine S.J., Bateman R.H.C., Clemmer D.E. Proceedings of the 54th Conference of the American Society for Mass Spectrometry May 28-June 1, 2006, (ThP05, 64).
32. Ruotolo B.T., Hyung S.J., Robinson P.M., Giles K., Bateman R.H.C., Robinson C.V. Ion Mobility-Mass Spectrometry Reveals Long-Lived, Unfolded Intermediates in the Dissociation of Protein Complexes. Angew. Chem. Int. Ed. 2007, 46:8001-8004.
33. Ruotolo B.T., Benesch J., Sandercock A., Hyung S.J., Robinson C.V. Ion Mobility-Mass Spectrometry Analysis of Large Protein Complexes. Nat. Protoc. 2008, 3:1139-1152.
34. Williams J.P., Scrivens J.H. Coupling Desorption Electrospray Ionization and Neutral Desorption/Extractive Electrospray Ionization with a Traveling-Wave Based Ion Mobility Mass Spectrometer for the Analysis of Drugs. Rapid Commun. Mass Spectrom. 2008, 22:187-196.
35. Williams J.P., Bugarcic T., A: Giles K., Campuzano I., Rodger P.M., Sadler P.J. Isomer Separation and Gas-Phase Configurations of Organoruthenium Anticancer Complexes: Ion Mobility Mass Spectrometry and Modeling. J. Am. Soc. Mass Spectrom. 2009, 20:1119-1122.
36. Scarff C.A., Thalassinos K., Hilton G.R., Scrivens J.H. Traveling Wave Ion Mobility Mass Spectrometry Studies of Protein Structure: Biological Significance and Comparison with X-ray Crystallography and Nuclear Magnetic Resonance Spectroscopy Measurements. Rapid Commun. Mass Spectrom. 2008, 22:3297-3304.
37. Thalassinos K., Grabenauer M., Slade S.E., Hilton G.R., Bowers M.T., Scrivens J.H. Characterization of Phosphorylated Peptides Using Traveling Wave-Based and Drift Cell Ion Mobility Mass Spectrometry. Anal. Chem. 2009, 81:248-254.
38. Smith D.P., Knapman T.W., Campuzano I., Malham R.W., Berryman J.T., Radford S.E., Ashcroft A.E. Deciphering Drift Time Measurements from Traveling Wave Ion Mobility Spectrometry-Mass Spectrometry Studies. Eur. J. Mass Spectrom. 2008, 15:113-130.
39. Clemmer D.E. On-Line Cross Section Database of Collision Cross Sections for Singly-Protonated Polyaminoacids http://www.indiana.edu/~clemmer/Research/cross%20section%20database/Pept ides/polyaminoacid_cs.htm.
40. Clemmer D.E. On-Line Cross Section Database of Collision Cross Sections of Individual Protein Charge States http://www.indiana.edu/~clemmer/Research/cross%20section%20database/Prot eins/protein_cs.htm.
41. Appleton T.G. Donor Atom Preferences in Complexes of Platinum and Palladium with Amino Acids and Related Molecules. Coord. Chem. Rev. 1997, 166:313-359.
42. Murdoch P.S., Ranford J.D., Sadler P.J., Berners-Price S.J. Cis-trans Isomerization of [bis(L-Methioninato)Platinum]: Metabolite of the Anticancer Drug Cisplatin. Inorg. Chem. 1993, 32:2249-2255.
43. Wilson C., Scudder M.L., Hambley T.W., Freeman H.C. Structures of Dichloro[(S)-Methionine-N,S]Platinum(II) and Chloro[glycyl-(S)-Methioninato-N,N',S]Platinum(II) Monohydrate. Acta Crystallogr. C: Cryst. Struct. Commun. 1992, C48:1012-1015.
44. 2. An Anti-Tumor Drug. Structure and Bonding 1972, 1. Springer-Verlag, Berlin. J.D. Dunitz, P. Hemmerich, J.A. Ibers, C.K. Jorgensen, N.B. Neilands, S.R.B. Nyholm, D. Reinen, R.J.P. Williams (Eds.).
45. Lempers E.L.M., Reedijk J. Reversibility of Binding of Cisplatin-Methionine in Proteins by Diethyldithiocarbamate or Thiourea: A Study with Model Adducts. Inorg. Chem. 1990, 29:217-222.
46. Vijay-Kumar S., Bugg C.E., Cook W.J. Structure of Ubiquitin Refined at 1.8 Ȧ Resolution. J. Mol. Biol. 1987, 194:531-544.
47. 15N NMR Spectroscopy. J. Biol. Inorg. Chem. 1999, 4:621-631.